A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides.
Human milk contains approximately 200 complex oligosaccharides believed to stimulate the growth and establishment of a protective microbiota in the infant gut. The lack of scalable analytical techniques has hindered the measurement of bacterial metabolism of these and other complex prebiotic oligosaccharides. An in vitro, multi-strain, assay capable of measuring kinetics of bacterial growth and detailed oligosaccharide consumption analysis by FTICR-MS was developed and tested simultaneously on 12 bifidobacterial strains. For quantitative consumption, deuterated and reduced human milk oligosaccharide (HMO) standards were used. A custom software suite developed in house called Glycolyzer was used to process the large amounts of oligosaccharide mass spectra automatically with (13)C corrections based on de-isotoping protocols. High growth on HMOs was characteristic of Bifidobacterium longum biovar infantis strains, which consumed nearly all available substrates, while other bifidobacterial strains tested, B. longum bv. longum, B. adolescentis, B. breve and B. bifidum, showed low or only moderate growth ability. Total oligosaccharide consumption ranged from a high of 87% for B. infantis JCM 7009 to only 12% for B. adolescentis ATCC 15703. A detailed analysis of consumption glycoprofiles indicated strain-specific capabilities towards differential metabolism of milk oligosaccharides. This method overcomes previous limitations in the quantitative, multi-strain analysis of bacterial metabolism of HMOs and represents a novel approach towards understanding bacterial consumption of complex prebiotic oligosaccharides.
Departments of Viticulture & Enology, Chemistry and Food Science & Technology, and Microbiology Graduate Group, University of California, Davis, CA 95616, USA.
Riccardo G
RG
Locascio
Milady R
MR
Niñonuevo
Scott R
SR
Kronewitter
Samara L
SL
Freeman
J Bruce
JB
German
Carlito B
CB
Lebrilla
David A
DA
Mills
D001644:Bifidobacterium / Q000737:chemistry / Q000254:growth & development / Q000378:metabolism*; D041981:Gastrointestinal Tract / Q000378:metabolism / Q000382:microbiology; D006801:Humans; D008895:Milk, Human / Q000737:chemistry / Q000378:metabolism*; D008954:Models, Biological; D009844:Oligosaccharides / Q000737:chemistry / Q000378:metabolism*; D012984:Software
D009844:Oligosaccharides
J Nutr. 2006 Aug;136(8):2127-30
16857829
J Nutr. 2007 Mar;137(3 Suppl 2):830S-7S
17311983
FEMS Microbiol Rev. 2004 Oct;28(4):405-40
15374659
J Biol Chem. 2003 Apr 18;278(16):14112-20
12562767
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18964-9
19033196
Br J Nutr. 2009 Feb;101(4):482-6
19230080
Antonie Van Leeuwenhoek. 2002 Aug;82(1-4):279-89
12369194
Gut. 2000 Nov;47(5):646-52
11034580
Anal Biochem. 2007 Feb 1;361(1):15-23
17181994
J Agric Food Chem. 2006 Oct 4;54(20):7471-80
17002410
Appl Environ Microbiol. 2006 Jun;72(6):4497-9
16751577
Pediatrics. 1993 Mar;91(3):637-41
8441573
J Agric Food Chem. 2007 Oct 31;55(22):8914-9
17915960
Int J Syst Evol Microbiol. 2002 Nov;52(Pt 6):1945-1951
12508852
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8957-62
12847288
Pediatrics. 2005 Jan;115(1):1-4
15629973
Anaerobe. 2003 Oct;9(5):219-29
16887708
Adv Exp Med Biol. 2001;501:315-23
11787697
J Bacteriol. 2006 Feb;188(4):1260-5
16452407
J Nutr. 1995 Jun;125(6):1401-12
7782892
J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S80-3
15220665
J Leukoc Biol. 2004 Oct;76(4):820-6
15240751